The Importance Of Ongoing Awareness In Glaucoma Patient

This case illustrates the typical challenges faced daily by ophthalmologists. Glaucoma necessitates continuous observation and treatment adjustments to meet the patient's needs. This case highlights the critical role of monitoring disease progression. Regular check-ups allow for early detection of disease progression and the implementation of appropriate therapeutic modifications, effectively counteracting progressive vision loss. Furthermore, this case emphasizes the necessity of an individualized approach to each patient. Glaucoma treatment often involves eye drops that can cause adverse effects such as conjunctival irritation or allergies. Therefore, treatment selection must consider both efficacy and patient comfort and preferences.

This case was managed within the Ophthalmology Department of the Kornel Gibiński University Clinical Center, Medical University of Silesia, Katowice, Poland.

A 68-year-old female with a history of long-standing glaucoma was admitted to the Ophthalmology Department for the purpose of lowering and stabilizing intraocular pressure in the left eye. Prior to hospitalization, intraocular pressure values in the left eye remained at the upper limits of normal during outpatient clinic visits, with a target pressure of 10 mmHg. The patient had been diagnosed with glaucoma in both eyes in 2012 and had undergone various antiglaucoma medications, selective laser trabeculoplasty, diode laser transscleral cyclophotocoagulation, and XEN gel stent surgery with mitomycin C. Diagnostic tests including static visual field, ultrasound biomicroscopy, visual evoked potential, head computed tomography were performed.

Despite multiple treatments, including topical and oral medications, selective laser trabeculoplasty, diode laser transscleral cyclophotocoagulation, and XEN gel stent, the target intraocular pressure of 10 mmHg in the left eye was not achieved. Ophthalmological examination revealed visual acuity of 1.0 in the right eye and 0.7 in the left eye, with intraocular pressures of 18 mmHg and 23 mmHg, respectively. Ultrasound biomicroscopy showed a shallow anterior chamber with the XEN gel stent visible. Visual evoked potentials indicated optic nerve atrophy in the left eye and possible compressive neuropathy. Head computed tomography revealed a meningioma in the right frontal region.

This case underscores the complexity of glaucoma management and the need for a personalized approach. Despite various therapeutic methods, complete disease control is not always achieved. In cases of refractory glaucoma, vigilance and the pursuit of new therapeutic solutions are essential. Optimal management requires continuous assessment of treatment efficacy and adaptation to individual patient needs. The coexistence of compressive and glaucomatous neuropathy poses a significant diagnostic challenge, necessitating thorough neurological evaluation.